Related Experiment Video
Updated: Jun 5, 2026
12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
Recent advances in robot-assisted radical cystectomy.
Eugene K Cha1, N Peter Wiklund, Douglas S Scherr
1Department of Urology, New York-Presbyterian Hospital, Weill Cornell Medical College, New York, USA.
Current Opinion in Urology
|December 21, 2010
Summary
Robot-assisted radical cystectomy shows promise for bladder cancer treatment, offering reduced complications and shorter hospital stays compared to open surgery. Further research is needed to confirm long-term oncologic outcomes.
Area of Science:
- Urology
- Surgical Oncology
- Minimally Invasive Surgery
Background:
- Robot-assisted radical cystectomy (RARC) is increasingly adopted for bladder cancer.
- It presents a minimally invasive alternative to open radical cystectomy (ORC).
Purpose of the Study:
- To review recent literature on RARC for bladder cancer treatment.
- To evaluate RARC as a minimally invasive option compared to ORC.
Main Methods:
- Literature review of recent case series and comparative studies.
- Analysis of perioperative morbidity and early oncologic outcomes.
Main Results:
- RARC demonstrates potential benefits: decreased blood loss, reduced transfusion rates, lower analgesic needs, and shorter hospital stays.
- Recent studies indicate fewer postoperative complications with RARC.
- Short-term oncologic outcomes and lymph node yields appear equivalent to ORC.
Conclusions:
- RARC is an emerging minimally invasive approach for radical cystectomy.
- Early data suggest improved perioperative outcomes with comparable short-term oncologic results to ORC.
- Long-term data and larger randomized trials are necessary for definitive evaluation.